Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Immuneering (IMRX) Leases (2020 - 2026)

Immuneering's Leases history spans 7 years, with the latest figure at $3.2 million for Q1 2026.

  • On a quarterly basis, Leases fell 9.87% to $3.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $3.2 million, a 9.87% decrease, with the full-year FY2025 number at $3.3 million, down 9.41% from a year prior.
  • Leases came in at $3.2 million for Q1 2026, down from $3.3 million in the prior quarter.
  • The five-year high for Leases was $4.8 million in Q1 2022, with the low at $3.2 million in Q1 2026.
  • Historically, Leases has averaged $4.0 million across 5 years, with a median of $3.9 million in 2024.
  • Peak annual rise in Leases hit 740.1% in 2022, while the deepest fall reached 17.21% in 2022.
  • Year by year, Leases stood at $4.4 million in 2022, then fell by 9.35% to $4.0 million in 2023, then fell by 8.22% to $3.7 million in 2024, then dropped by 9.41% to $3.3 million in 2025, then fell by 2.76% to $3.2 million in 2026.
  • Business Quant data shows Leases for IMRX at $3.2 million in Q1 2026, $3.3 million in Q4 2025, and $3.4 million in Q3 2025.